Heterojunction semiconductor nanocatalysts as cancer theranostics

What is it about?

This review summarizes the recent applications of exogenous stimulus-responsive semiconducting nanoheterojunctions for cancer theranostics. The first part of the review outlines the construction of different heterojunction types. The next section summarizes recent designs, properties, and catalytic mechanisms of various semiconductor heterojunctions in tumor therapy. The review concludes by discussing the challenges and providing insights into their prospects within this dynamic and continuously evolving field of research.

Featured Image

Photo by National Cancer Institute on Unsplash

Photo by National Cancer Institute on Unsplash

Why is it important?

This review explores the basic working principles of semiconductor heterojunction catalysts. It clarifies the latest progress in designing and utilizing heterojunctions for tumor theranostics applications. Then, the review examines strategies to optimize existing heterojunctions and explores their potential for future therapeutic approaches beyond cancer treatment. It discusses the exciting prospects for integrating heterojunctions into different biomedical fields. Ultimately, this review summarizes and discusses the reported literature on exogenously activated semiconducting nano-heterojunctions in the field of cancer medicine, aiming to inspire further innovation and promote the development of heterojunctions as powerful tools for advancing biomedicine.